Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 950.00
Bid: 954.00
Ask: 963.00
Change: -3.00 (-0.31%)
Spread: 9.00 (0.943%)
Open: 975.00
High: 975.00
Low: 936.00
Prev. Close: 953.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GCAP to make available GEL 300mn for buybacks

17 May 2024 07:00

RNS Number : 8192O
Georgia Capital PLC
17 May 2024
 

London, 17 May 2024

 

Georgia Capital PLC to make available at least GEL 300 million for share buyback and cancellation programmes through the end of 2026 from expected cash inflows

Georgia Capital PLC (the "Company", "Georgia Capital" or "GCAP") announces today its board of directors' (the "Board") intention to make available at least GEL 300 million (c.US$ 110 million) for share buyback and cancellation programmes through the end of 2026. These programmes will be funded from expected cash inflows.

Georgia Capital has delivered a strong recent financial and operational performance:

· The Company's gross debt balance has been reduced from US$ 365 million to US$ 150 million over the last two years, significantly improving its leverage profile.

· Significant progress has been achieved in GCAP's free cash flow generation capabilities. GCAP's free cash flow improved from negative US$ 10 million in 2020 to positive US$ 48 million[1] in 2023. This reflects robust organic dividend inflows, well-managed operating expenses and reduced interest expense in line with the significant reduction in borrowings.

· Strong balance sheet management has translated into a material improvement in the Net Capital Commitment ("NCC") ratio, which has recently decreased below the through-the-cycle target level of 15%, ahead of the originally planned timeline of end 2025.

The Board is confident in the Company's expected future cash inflows through the end of 2026 and expects that free cash flow will be in excess of US$ 200 million during this period. In line with the Company's 360-degree capital management framework, the strong level of free cash flow generation enables GCAP to seize the attractive opportunity presented by the current c.60% discount to the last reported NAV per share[2] and create significant value for our shareholders through share buybacks.

Since our demerger from BGEO Group in 2018, GCAP has repurchased and cancelled 7.9 million shares (US$ 87 million in value), representing c.16.5% of the issued share capital at its peak. These buybacks have not only provided significant accretion to the NAV per share and enhanced share liquidity, but have also underscored the Board's confidence in the underlying valuation of GCAP's portfolio. Share buybacks, to be executed under the announced package, represent c.20% of GCAP's current market capitalisation. This marks a substantial increase in our investment in GCAP shares compared to buybacks carried out in the past six years following the demerger.

Simultaneous with this announcement, we are today launching a US$ 25 million (GEL 70 million) share buyback and cancellation programme as part of the above-mentioned at least GEL 300 million package. The Company will make further announcements in due course, taking into account prevailing market conditions, regarding the commencement of further buyback and cancellation programmes.

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Giorgi Alpaidze, Chief Financial Officer

About Georgia Capital PLC

Georgia Capital (LEI: 213800Q65T5GNBOW7H65) is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Company's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a renewable energy business (hydro and wind assets), (v) an education business and (vi) a clinics and diagnostics business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 19.7% equity stake (at 31-Mar-24) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit rating:

S&P Global

'BB-'/FC & 'BB-'/LC

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities.

 

 

 

 

 

 

 

 


[1] Excludes one-off dividends.

[2] Reflects recent movements in BoG's share price and foreign exchange rates.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFILEIIRLIS
Date   Source Headline
31st May 20245:29 pmRNSCancellation of Treasury Shares
31st May 20245:29 pmRNSTransaction in Own Shares
30th May 20245:06 pmRNSTransaction in Own Shares
29th May 20245:55 pmRNSTransaction in Own Shares
28th May 20244:33 pmRNSTransaction in Own Shares
24th May 20245:13 pmRNSTransaction in Own Shares
23rd May 20245:11 pmRNSTransaction in Own Shares
23rd May 20245:03 pmRNSDirector/PDMR Shareholding
22nd May 20245:36 pmRNSTransaction in Own Shares
22nd May 20242:34 pmRNSDirector/PDMR Shareholding
21st May 20245:22 pmRNSTransaction in Own Shares
20th May 20245:46 pmRNSTransaction in Own Shares
20th May 20241:55 pmRNSResult of AGM
17th May 20245:34 pmRNSTransaction in Own Shares
17th May 20247:00 amRNSCommencement of US$ 25mn share buyback programme
17th May 20247:00 amRNSGCAP to make available GEL 300mn for buybacks
1st May 20247:00 amRNS1st Quarter Results
24th Apr 202412:30 pmRNSNotice of Results
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 202410:52 amRNSChange of Registered Office
3rd Apr 20245:29 pmRNSDirector/PDMR Shareholding
25th Mar 20245:29 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSAnnual Financial Report
14th Mar 20245:13 pmRNSDirector/PDMR Shareholding
29th Feb 202410:13 amRNSCancellation of Treasury Shares
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
23rd Feb 20243:58 pmEQSEdison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms
23rd Feb 20241:13 pmRNSTransaction in Own Shares
22nd Feb 20245:23 pmRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSFinal Results
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:18 pmRNSTransaction in Own Shares
19th Feb 20242:19 pmRNSTransaction in Own Shares
16th Feb 20244:29 pmRNSTransaction in Own Shares
15th Feb 20244:24 pmRNSTransaction in Own Shares
15th Feb 20243:15 pmRNSNotice of Results
14th Feb 20245:05 pmRNSTransaction in Own Shares
13th Feb 20243:19 pmRNSTransaction in Own Shares
9th Feb 20245:12 pmRNSTransaction in Own Shares
8th Feb 20245:17 pmRNSTransaction in Own Shares
7th Feb 20244:45 pmRNSTransaction in Own Shares
6th Feb 20243:23 pmRNSTransaction in Own Shares
5th Feb 20244:48 pmRNSTransaction in Own Shares
2nd Feb 20241:40 pmRNSTransaction in Own Shares
1st Feb 20244:57 pmRNSTransaction in Own Shares
1st Feb 202411:49 amRNSTotal Voting Rights
31st Jan 20245:03 pmRNSCancellation of Treasury Shares
31st Jan 20244:48 pmRNSTransaction in Own Shares
30th Jan 20243:26 pmRNSTransaction in Own Shares
29th Jan 20242:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.